The lysophospholipase D enzyme Gdpd3 is required to maintain chronic myelogenous leukaemia stem cells
How lipid metabolism can affect cancer recurrence is still unclear. Here, the authors show that the lysophospholipase D Gdpd3 maintains self-renewal capacity of CML stem cells by regulating the quiescence, and AKT/mTORC1 and Foxo3a/β-catenin signalling in an oncogene-independent manner.
Guardado en:
Autores principales: | Kazuhito Naka, Ryosuke Ochiai, Eriko Matsubara, Chie Kondo, Kyung-Min Yang, Takayuki Hoshii, Masatake Araki, Kimi Araki, Yusuke Sotomaru, Ko Sasaki, Kinuko Mitani, Dong-Wook Kim, Akira Ooshima, Seong-Jin Kim |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/73aca2b556d542e499ca1a950b353d8d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Dynamics and potential impact of the immune response to chronic myelogenous leukemia.
por: Peter S Kim, et al.
Publicado: (2008) -
Bosutinib in the management of chronic myelogenous leukemia
por: Keller-von Amsberg G, et al.
Publicado: (2013) -
Spotlight on nilotinib in the treatment of chronic myelogenous leukemia
por: Harnicar S, et al.
Publicado: (2014) -
Human AQP5 plays a role in the progression of chronic myelogenous leukemia (CML).
por: Young Kwang Chae, et al.
Publicado: (2008) -
Tipifarnib in the treatment of newly diagnosed acute myelogenous leukemia
por: Judith E Karp, et al.
Publicado: (2008)